DPIIT recognised startup Government of India
Startup India
Rozer Pharmaceuticals Private Limited
Rozer Pharmaceuticals Private Limited - business services in Kalyan, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹62.21 Lakh
▲ 22% YoY
Net profit · FY 2025
₹1.5 Lakh
Net margin 2.4%
EBITDA · FY 2025
₹2.24 Lakh
EBITDA margin 3.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Rozer Pharmaceuticals Private Limited
Data last updated:
Rozer Pharmaceuticals Private Limited is a private limited company based in Kalyan, Maharashtra, India, recognised as a startup by DPIIT. It operates in the service-based operations segment of the business services sector. It was incorporated on 07 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2019PTC319151. Its GSTIN is 27AAJCR3406M1Z3 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nitin Pandit Tayade and Raju Harishchandra Jaiswal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalyan, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹62.21 Lakh, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹1.5 Lakh (net margin 2.4%) and EBITDA of ₹2.24 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 21% over five years.
Rozer Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0029949).
Company details
CIN U74999MH2019PTC319151
Registration Number 319151
Incorporation Date 07 January 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-27-0029949
Recognitions & Rankings of Rozer Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-27-0029949
Contact details
Rozer Pharmaceuticals Private Limited's registered office is in Kalyan, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. B1/003 Shree Sai Gajanan Chs Ltd Milkat Number 003, Location Near Tukaram Chauk Dombivali East Village Dawadi, Kalyan, Maharashtra, India – 421203
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Rozer Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Rozer Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rozer Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rozer Pharmaceuticals Private Limited, buy the company report.
Financials of Rozer Pharmaceuticals Private Limited
FY 2025 filings availableRozer Pharmaceuticals Private Limited reported revenue of ₹62.21 Lakh (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹62.21 Lakh ▲ 22%
Net profit · FY 2025
₹1.5 Lakh margin 2.4%
EBITDA · FY 2025
₹2.24 Lakh margin 3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 28%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▲ 65%
3 years · compounded
▲ 31%
5 years · compounded
▲ 56%
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 22% growth in the latest year. EBITDA rose 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rozer Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rozer Pharmaceuticals Private Limited
Rozer Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Pandit Tayade | Director | 15 Jun 2021 | 5 Years 4 Months | Current |
| Raju Harishchandra Jaiswal | Director | 07 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Rozer Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reetosh Pharmaceuticals Private Limited | ₹62.54 Lakh (FY 2025) | 16.0% | Ranchi, Jharkhand, India | |||
| Allegro Pharmaceuticals Private Limited | ₹62.32 Lakh (FY 2023) | 3.0% | Kozhikode, Kerala, India | |||
| Nevcare Pharmaceuticals Private Limited | ₹62.24 Lakh (FY 2024) | 155.0% | Thane, Maharashtra, India | |||
| Rozer Pharmaceuticals Private Limitedthis company | ₹62.21 Lakh (FY 2025) | ₹1.5 Lakh | 2.4% | 22.0% | Kalyan, Maharashtra, India | |
| Mezon Pharmaceuticals Private Limited | ₹62.12 Lakh (FY 2024) | -16.0% | Ludhiana, Punjab, India | |||
| Kaansla Pharmaceuticals Private Limited | ₹62.11 Lakh (FY 2025) | 58.0% | Panchkula, Haryana, India | |||
| Resilio Pharmaceuticals Private Limited | ₹62.1 Lakh (FY 2024) | 10.0% | Hyderabad, Telangana, India | |||
| Meracus Pharmaceuticals Private Limited | ₹62 Lakh (FY 2024) | 31.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Rozer Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rozer Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rozer Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rozer Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCR3406M1Z3 | Maharashtra | Active | 14 Feb 2019 |
To see the full GST registrations and return filing status of Rozer Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rozer Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Chandan Kumar ceased to be Director on 28 Jun 2021.
AGM
Rozer Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rozer Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Chandan Kumar ceased to be Director.
Appointed
Nitin Pandit Tayade was appointed as Director.
Ceased
Laxman Yashwant Phonde ceased to be Director.
Appointed
Raju Harishchandra Jaiswal was appointed as Director.
Incorporation
07 Jan 2019
Rozer Pharmaceuticals Private Limited was registered on 07 Jan 2019 with Roc Mumbai I & aged 7 years 9 months as per MCA records.
Frequently asked questions
Rozer Pharmaceuticals is an active private limited company based in Kalyan, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 07 January 2019 (7+ years old) and is registered under CIN U74999MH2019PTC319151.
Rozer Pharmaceuticals has 2 current directors:
- Nitin Pandit Tayade - Director
- Raju Harishchandra Jaiswal - Director
The latest financial statements of Rozer Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Rozer Pharmaceuticals is 27AAJCR3406M1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Rozer Pharmaceuticals is U74999MH2019PTC319151. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rozer Pharmaceuticals was incorporated on 07 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Rozer Pharmaceuticals by revenue are Reetosh Pharmaceuticals Private Limited, Allegro Pharmaceuticals Private Limited, Nevcare Pharmaceuticals Private Limited, Mezon Pharmaceuticals Private Limited, Kaansla Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Chandan Kumar ceased to be Director on 28 Jun 2021. Nitin Pandit Tayade was appointed as Director on 15 Jun 2021. Laxman Yashwant Phonde ceased to be Director on 25 Mar 2019. Rozer Pharmaceuticals has 4 board changes on record in total.
Yes, Rozer Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Rozer Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0029949).
The registered office of Rozer Pharmaceuticals is at Shop No. B1003 Shree Sai Gajanan Chs Ltd Milkat Number 003, Location Near Tukaram Chauk Dombivali East Village Dawadi, Kalyan, Maharashtra, India – 421203.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages